Clomipramine in the prevention of migraine

Abstract

Clomipramine was compared with placebo in the prevention of migraine headache. Both treatments reduced the frequency of attack markedly but there was no significant difference between the two. The severity of the attack was reduced in both cases but not significantly. The duration of attack was not affected. Significantly more side-effects were seen in the clomipramine group.